Bladder Cancer

Defining Cisplatin Eligibility in Patients with Muscle-Invasive Bladder Cancer - Beyond the Abstract April 14, 2021

Clinical Trial of High Dose Hyperthermic Intravesical Mitomycin C for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer During BCG Shortage - Beyond the Abstract April 1, 2021

A Review of Adaptive Radiotherapy for Bladder Cancer - Beyond the Abstract March 31, 2021

Adjuvant Radiotherapy After Radical Cystectomy for Muscle-Invasive Bladder Cancer - Beyond the Abstract March 26, 2021

Investigating the Association Between the Urinary Microbiome and Bladder Cancer: An Exploratory Study - Beyond the Abstract March 23, 2021

Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy - Beyond the Abstract March 5, 2021

Midterm Follow-up (3 Years) Confirms and Extends Short-Term Results of Intravesical Gemcitabine as Bladder-Preserving Treatment for Non-Muscle-Invasive Bladder Cancer After BCG Failure - Beyond the Abstract February 24, 2021

Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer - Beyond the Abstract February 9, 2021

Bladder Tumor Subtype Commitment Occurs in Carcinoma In-Situ Driven by Key Signaling Pathways Including ECM Remodeling - Beyond the Abstract February 3, 2021

Validation of the Khorana Score for Prediction of Venous Thromboembolism After Robot-Assisted Radical Cystectomy - Beyond the Abstract January 27, 2021

Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy - Beyond the Abstract January 25, 2021

[18F]Fluoro-Deoxy-Glucose Positron Emission Tomography to Evaluate Lymph Node Involvement in Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Pembrolizumab - Beyond the Abstract January 22, 2021

Can Anesthetics Affect Bladder Cancer Recurrence? Total Intravenous Versus Volatile Anesthesia in Patients Undergoing Robot-Assisted Radical Cystectomy: A Single Institution Retrospective Analysis - Beyond the Abstract January 22, 2021

Can Immune Markers Help Identify Fast Relapse in Patients With Muscle Invasive Bladder Cancer? - Beyond the Abstract January 21, 2021

Intracorporeal Versus Extracorporeal Urinary Diversion Following Robot-Assisted Radical Cystectomy: A Meta-Analysis, Cumulative Analysis, and Systematic Review - Beyond the Abstract January 15, 2021

Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) Program - Beyond the Abstract January 14, 2021

Identification of a Synthetic Lethal Relationship Between Nucleotide Excision Repair (NER) Deficiency and Irofulven Sensitivity in Urothelial Cancer - Beyond the Abstract January 12, 2021

Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract January 11, 2021

Association Between Metabolic Syndrome and Recurrence of Nonmuscle-Invasive Bladder Cancer in Older Adults - Beyond the Abstract January 4, 2021

Current Treatments for BCG Failure in Non-Muscle Invasive Bladder Cancer - Beyond the Abstract December 10, 2020

Page 1 of 16